Mary J Landkamer-tagatz, PHD | |
161 Spring St, Westfield, WI 53964-9068 | |
(608) 296-2139 | |
Not Available |
Full Name | Mary J Landkamer-tagatz |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 161 Spring St, Westfield, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083881924 | NPI | - | NPPES |
39675300 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 1634 - 123 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mary J Landkamer-tagatz, PHD 161 Spring St, Westfield, WI 53964-9068 Ph: (608) 296-2139 | Mary J Landkamer-tagatz, PHD 161 Spring St, Westfield, WI 53964-9068 Ph: (608) 296-2139 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.0 million financing with two existing institutional shareholders, both of which are affiliates of Xmark Opportunity Partners, LLC.
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
Even mild head injuries can cause significant abnormalities in brain function that last for several days, which may explain the neurological symptoms experienced by some individuals who have experienced a head injury associated with sports, accidents or combat, according to a study by Virginia Commonwealth University School of Medicine researchers.
A drug currently approved for osteoporosis treatment has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as an important supplemental therapy in patients with head and neck cancers that erode bone.
› Verified 2 days ago